The LGF clinical study is now published in INNOVATION - Technologies and Techniques in Cardiothoracic and Vascular Surgery. 
The study was conducted as a separate trial in ten patients undergoing endovascular aortic repair. The LGF was deployed in the Hypogastric artery from a cross over access. 3N of tension was applied to the guidewire to verify guidewire fixation. The LGF was then retrieved and the artery was inspected for any sign of trauma using angiography and a 30 days post operative CT-scan. 
Deployment was uneventful in all ten patients. Retrieval according to the intended instruction for use was performed in nine of the patients. In one patient, a coaxial catheterization was necessary. All devices withstood a retention force of 3 N.

 “This study was aimed to investigate and verify the pre-clinical results from porcine models, and the results are very similar, no dissection or vessel trauma so far. The device has been designed to produce an evenly distributed, radial force against the vessel wall, which reduces the risk for dissection. In my opinion dissection often occurs due to pointy tools, often guidewires, that penetrates the initima.” Says Krister Liungman, Founder and Head of Clinical at Endovab

News archive


Latest news